Need professional-grade analysis? Visit stockanalysis.com
$9.75B
609.50
2,169
0.12%
Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A (301246) trades on SHE in CNY. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at CNY24.30, down 0.41% from the previous close.
Over the past year, 301246 has traded between a low of CNY12.74 and a high of CNY26.88. The stock has gained 86.3% over this period. It is currently 9.6% below its 52-week high.
Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A has a market capitalization of $9.75B, with a price-to-earnings ratio of 609.50 and a dividend yield of 0.12%.
Hubei Hongyuan Pharmaceutical Technology Co., Ltd., together with its subsidiaries, produces and sells pharmaceutical products in China and internationally. The company offers active pharmaceutical ingredients, such as metronidazole, benzoyl metronidazole, dimetrizole, and acyclovir; pharmaceutical intermediates, including imidazole, glyoxylic acid, 2-methyl imidazole, 2-methyl-5-nitroimidazole, sulfate, guanine, diacetyl guanine, and diacetylacyclovir; organic chemical raw materials comprising glyoxal, and oxalic acid; and new energy materials consisting of lithium hexafluorophosphate. It also is involved in the production and sales of triamines, guanine and other products; research and development, production, and sales of pharmaceutical preparations; trading of APIS, pharmaceutical intermediates, organic chemical raw materials, etc.; fluoride salts and other fluorine-containing chemical products; and pharmaceutical wholesale, retail, etc. Hubei Hongyuan Pharmaceutical Technology Co., Ltd. was founded in 2002 and is headquartered in Huanggang, China.
Side-by-side comparison against top Healthcare peers.